Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2015 | 2014 |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2012 Research Grants

Carl June, M.D.
Gregory Beatty, M.D., Ph.D.
Mesothelin-specific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pancreatic Cancer
University of Pennsylvania

Douglas T. Fearon, M.D.
Dissection of Cancer-Induced Cachexia and Muscle Wasting
Cambridge Research Institute UK

Mikala Egeblad, Ph.D.
Scott Lowe, Ph.D.
Dynamics of Development and Maintenance of Tumor-Stroma Interactions in Pancreatic Cancer.
Cold Spring Harbor Laboratory
Memorial Sloan Kettering Cancer Center

Timothy C. Wang, M.D.
Role of Neurons in the Development and Progression of Pancreatic Cancer.
Columbia University 

Alec Kimmelman, M.D., Ph.D.
Lewis Cantley, Ph.D.
Luke Lairson, Ph.D.
Development of Small Molecule Inhibitors of the Pancreatic Cancer Metabolism.
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Institute
Scripps Research Institute

Sunil Hingorani, M.D., Ph.D.
Mechanisms Driving Interstitial Fluid Pressures in PDA
Fred Hutchinson Cancer Research Center

William C. Hahn, M.D., Ph.D.
Sangeeta Bhatia, M.D., Ph.D.
Charles Fuchs, M.D.
Treatment of Pancreatic Cancer by Tumor-Penetrating Delivery of siRNA
Harvard Medical School
Massachusetts Institute of Technology
Dana Farber Cancer Institute

Bert Vogelstein, M.D.
Peter Allen, M.D.
Max Schmidt, M.D., Ph.D.
Detection of Early Pancreatic Neoplasia
Johns Hopkins University 
Memorial Sloan Kettering Cancer Center
University of Indiana

David Tuveson, M.D., Ph.D.
Pancreatic Cancer Biology and Therapy
The Lustgarten Foundation Pancreatic Cancer Laboratory
Cold Spring Harbor Laboratory

Eileen O'Reilly, M.D.
David Kelsen, M.D.
Testing Promising Drug Combinations in BRCA1 and BRCA2 Patients
Memorial Sloan Kettering Cancer Center

Ken Olive, Ph.D.
Focused Ultrasound Technologies for Diagnosis, Monitoring,and Treatment of Pancreatic Cancer
Columbia University

Dafna Bar-Sagi, Ph.D.
Harnessing the Metabolic Vulnerability of Pancreatic Cancer Cells to Develop Novel Therapies
New York University

George Miller, M.D.
Analysis of the Effects of the Intestinal Microbiome in Pancreatic Cancer
New York University 

Tyler Jacks, Ph.D.
Combination Therapies Targeting K-ras Pathways
Massachusetts Institute of Technology

Daniel Von Hoff, M.D.,FACP 
Craig Thompson, M.D.
Stand Up To Cancer Dream Team Translational Cancer Research Grant
Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer
Translational Genomics Research Institute
Memorial Sloan Kettering Cancer Center

Teresa A. Zimmers, Ph.D.
Building a Map of Pancreatic Cancer Cachexia and Muscle Wasting
Thomas Jefferson University 

Roger Y. Tsien, Ph.D.
Magnetic Resonance Imaging of Pancreatic Cancer with Contrast Agents Targeted by Activatable Cell-Penetrating Peptides 
University of California, San Diego

Jen Jen Yeh, M.D.
Defining the Pancreatic Cancer Kinome Landscape
University of North Carolina

Stephen Thorne, Ph.D.
Novel Oncolytic Vaccine Strains for Targeted Pancreatic Cancer Therapy
University of Pittsburgh

H. Charles Manning, Ph.D.
Novel TSPO PET Ligands to Image Pancreatic Cancer
Vanderbuilt University

Hadassa Degani, Ph.D.
Development of Multi-Parametric Magnetic Resonance Imaging Approach for Early Pancreatic Cancer Diagnosis.
Weizmann Institute of Science

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265


2015 website development and design sponsored by Celgene